ANDERSON ELIZABETH M

Director Elizabeth M Anderson sold 5,000 INSM shares at $204.58; stock up 24.7% in 30d, 51.5% in 90d amid unprofitable operations.

Director Elizabeth M Anderson sold 5,000 shares (5.0K shares) on 2025-11-24 at $204.58, reducing her position by 7.8% to 58,729 shares (58.7K shares). The stock has appreciated 24.7% over the prior 30 days and 51.5% over 90 days, now trading at $204.51, only 2.2% below its 52-week high of $209.02. This sale occurs within a period of sustained momentum in a stock that has doubled from its 52-week low of $64.81. The company reported revenue of $142,342,000.00 ($142.3M) in the latest quarter with annual revenue growth of 19.2%, but net income was $-370,021,000.00 ($-370.0M) for the most recent full fiscal year, indicating significant profitability challenges despite top-line growth. The director's transaction history at this ticker is limited (only 1 prior trade, a sell on 2025-11-14), providing minimal pattern context for timing assessment.

Director Anderson sold 10,000 INSM shares at $195.87 as stock hits 52-week high of $201.62

Director Elizabeth M. Anderson sold 10,000 shares (13.6% of her prior holdings) at $195.87, reducing her stake from 73.7K to 63.7K shares. The sale occurred near the company's 52-week peak—the stock currently trades at $201.62, only 0.0% below its 52-week high—and follows a 55.8% appreciation over the prior 90 days. This context is noteworthy given that INSM is unprofitable (full-year net income was $-370.0M despite 19.2% annual revenue growth to $142.3M), meaning the stock's strength is driven by investor conviction in future turnaround prospects rather than current earnings. The sale by a board member at or very near peak valuations, while the company remains deeply loss-making, merits investor scrutiny of the gap between market expectations and operational reality.